Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra ™ ...

AMSTERDAM -- A cardiac resynchronization therapy (CRT) upgrade produced solid clinical benefit for patients with pacing-induced heart failure with reduced ejection fraction (HFrEF), the small BUDAPEST ...

Bloomberg reminds us that CRT pacers are pricey, at about $8,000 each, which nearly doubles the cost of older pacemakers. As well, patients with the weakest hearts already are given the newer devices, ...

Boston Scientific is recalling Ingenio family of pacemakers (includes models Advantio DR EL, Ingenio DR EL, and Vitalio DR EL) and cardiac resynchronization therapy pacemakers (CRT-Ps) due to the risk ...

This week Cambridge Consultants unveiled a semi-leadless pacemaker it designed for start-up EBR Systems. The device, called Wireless Cardiac Stimulation system (WiCS), includes a leadless electrode ...

A typical implantation of a CRT-P with its three leads and use of an anti-infective envelope would require five ICD-10-PCS codes. Q: We are having trouble with a case that involves an Implantation of ...

BOSTON - With the advent of new therapies, cancer patients are surviving longer than ever before -- but the incidence of side-effect chemotherapy-induced cardiomyopathy (CHIC), or weakness of the ...